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Among procyanidins (PC), monomers, such as catechin and epicatechin, have been widely studied, whereas dimer and trimer oligomers have
received much less attention, despite their abundance in our diet. Recent studies have showed that as dimers and trimers could be important in
determining the biological effects of procyanidin-rich food, understanding their bioavailability and metabolism is fundamental. The purpose
of the present work is to study the stability of PC under digestion conditions, the metabolism and the bioavailability by using a combination
of in vitro and in vivo models. Simultaneously, the matrix effect of a carbohydrate-rich food on the digestibility and bioavailability of PC is
investigated. The results show a high level of stability of PC under gastric and duodenal digestion conditions. However, the pharmacokinetic
study revealed limited absorption. Free forms of dimers and trimers have been detected in rat plasma, reaching the maximum concentration
1 h after oral intake of a grape seed extract.
Procyanidins: Dimers: Trimers: Digestion: Bioavailability
Procyanidins (PC) are found in most plants and in a wide
range of foods, such as red wine, cocoa, tea and fruits, and
thus they are a part of the human diet. PC belong to the
group of flavonoids, and are phenolic compounds mainly
formed of (þ)-catechin and (2 )-epicatechin units with
C4–C8 and/or C4–C6 bonds. PC are formed from the conden-
sation of monomeric units, between two and five units for
oligomers and over five units for polymers(1).
Grape seed procyanidin extracts (GSPE) have shown sev-
eral bioactivities. They improve antioxidant cell defences(2)
and the plasma lipid profile(3,4), limit adipogenesis(5) and func-
tion as insulinomimetic(6) and anti-inflammatory(7) agents.
A preliminary study of an in vitro model by the authors has
also determined that dimeric and trimeric oligomers are the
most powerful PC molecules that mimic the complete
GSPE(8). Thus, to explain these health effects of PC and
understand the mechanism by which PC act at the cellular
level in vivo, it is essential to determine PC stability during
the digestive process as well as their bioavailability.
Despite it being clear that monomers are absorbed in human
subjects and animals, there are controversies about the bio-
availability of oligomeric forms. Different studies, following
the ingestion of chocolate(9 – 12), black and green tea(13 – 16),
red wine(17,18) and grape seed extract(1), have shown that
during digestion, the oligomers are fragmented into mono-
meric units of catechin and epicatechin. These are then
absorbed, appearing in plasma and urine primarily as glucur-
onidated, methylated and sulphated metabolites. A study by
Rios et al. (19) with six healthy subjects who consumed a
rich PC cocoa beverage studied the depolymerisation of PC
in the stomach and proved that they were remarkably stable
in the stomach environment. Another study by Sano et al. (20)
was the first work to detect procyanidin B1 in human serum
after oral intake of a GSPE, the maximum concentration
appearing 2 h after intake. As well as stability during diges-
tion, the dose of intake could determine the primary site of
phenol metabolism. Large doses are metabolised primarily
in the liver, and small doses may be metabolised by the intes-
tinal mucosa, with the liver playing a secondary role to further
modify the polyphenol conjugates from the small intestine(21).
The bioavailability of polyphenols has been also reviewed,
especially to focus on intestinal absorption and the influence
of their chemical structure (for example glycosylation, esteri-
fication and polymerisation) and the effect of the food matrix
composition(22). Different studies have been carried out into
the interaction between polyphenols and a food matrix such
as milk(23,24), olive oil(25) or sugar(26). The evidence suggests
that variations in polyphenol absorption also occur due to
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interactions between polyphenols and other food components.
For example, some authors suggest that the carbohydrate com-
position of the meal may influence flavonoid absorption
through an effect on the motility of gastric secretions and
hepatic blood flow(26). The polyphenol–protein interaction
has also been studied, and shown to be similar to antigen–
antibody interactions. The results of these studies suggest
that interactions may occur between digestive proteins and
monomers and dimers of flavanols from grape seed extract
during pancreatic digestion(27).
Nevertheless, one of the most important limitations of the
bioavailability studies in human subjects or animal models is
related to inter-individual variability. In vitro digestion
models are a very useful tool for studying the stability of
food components and evaluating the potential effects of the
food matrix on their bioavailability. Reviewing the literature,
a wide range of in vitro digestion methods have been designed
to simulate the effect of digestion on food or food components
and study its consequences. In vitro digestion methods can be
classified into two categories(28): static(29); dynamic(30,31) gas-
trointestinal models. The static models simulate the transit of
alimentary bolus through the human digestive tract by sequen-
tial exposure of food to simulated mouth, gastric and small
intestinal conditions. In contrast, the dynamic gastrointestinal
models mimic the gradual transit of ingested compounds
through the digestive tract.
Other important limitation related to the study of PC bio-
availability concerns the low concentration of their metabolites
in biological samples(1). Therefore, measuring them requires a
precise, robust, sensitive and selective analytical technique that
allows them to be identified and quantified. Liquid chromato-
graphy with MS is a powerful tool for both confirmatory
and quantitative analyses in complex matrices due to its high
sensitivity and selectivity. Apart from the analytical technique,
the use of an adequate extraction procedure to minimise the
matrix effects is very important.
As PC dimers and trimers could be important in determin-
ing the biological effects of PC-rich food, understanding the
bioavailability and metabolism of PC oligomers is fundamen-
tal. The objective of the present research is to study the stab-
ility of PC under digestion conditions, the metabolism and the
bioavailability by using a combination of in vitro and in vivo
models. Simultaneously, the matrix effect of a carbohydrate-
rich food on digestibility and bioavailability of PC is
investigated.
Experimental methods
Chemicals and reagent
A GSPE was used as the source of PC. The PC content of the
extract was .75 % (monomers 22 %, dimers 20 % and trimers
to pentamers 56 %). The composition of commercial cereal-
based food, used as carbohydrate-rich food, was as follows:
starch (hydrolysed wheat, wheat, barley, maize and oats); malt
extract; mineral salts (Ca, Fe and Zn); vitamins (C, niacin,
E, thiamine, A, B6, B9 and D); flavouring (vanillin).
Internal standard catechol and the standards of (2 )-epicate-
chin and (þ)-catechin were purchased from Sigma Aldrich
(St Louis, MO, USA); procyanidin B2 from Fluka Co.
(Buchs, Switzerland) and trimer was isolated from phenolic
extract obtained from cocoa nibs(32) using the technique
described by Serra et al. (33). The cocoa nibs were kindly
donated by La Morella Nuts, S.A. (Reus, Spain). Individual
stock standard solutions and the internal standard were
dissolved in methanol and stored in a dark-glass flask at
2188C. Standard mixtures, at different concentrations, were
prepared by appropriate dilution of the stock solutions, and
these were stored in dark-glass flasks at 48C before chromato-
graphic analysis.
Acetonitrile (HPLC grade), methanol (HPLC grade),
acetone (HPLC grade) and glacial acetic acid ($99·8 %)
were of analytical grade (Scharlab, Barcelona, Spain).
Ultrapure water was obtained from a Milli-Q water purifi-
cation system (Millipore Corporation, Bedford, MA, USA).
Simulated gastrointestinal digestion
A gastrointestinal in vitro digestion model was performed
based on the methodology described by Ortega et al. (34).
The discontinuous model describes a three-step procedure to
mimic the digestive process in the mouth, stomach (gastric
digestion) and small intestine (duodenal digestion) (Fig. 1).
In order to evaluate the food matrix effect, two different
samples were subjected to the digestion model: 300 mg PC
extract (GSPE); 300 mg GSPE þ 600 mg carbohydrate-rich
food. After the gastric step, the digestion mixture was
placed in tubes and centrifuged for 15 min at 12 000 g at
48C, yielding the chyme (supernatant or soluble fraction)
and the pellet (cloud or non-soluble fraction)(34). Both frac-
tions, the chyme and pellet, were freeze-dried (BMG Labtech,
Fig. 1. (a) Steps of the proposed in vitro digestion model. (b) Schema of the
duodenal digestion with dynamic dialysis. DD, duodenal mixture (fraction
found inside dialysis solution (IN)); PBS (fraction found outside dialysis
solution (OUT)).
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Offenburg, Germany) and stored for chromatographic analysis
of the PC content.
At the end of the dialysed duodenal digestion step, two frac-
tions were collected and analysed separately(34): the outside
dialysis solution (OUT) (Fig. 1), which was considered the
dialysable fraction; and the inside dialysis tub content (IN),
referring to the non-dialysable fraction. The dialysable frac-
tion (OUT) is considered the fraction that could be available
for absorption into the systematic circulation by passive diffu-
sion; while the non-dialysable fraction (IN) is attributed to the
digested fraction that would reach the colon fermentation
intact. Both fractions were freeze-dried and stored for chroma-
tographic analysis of the PC content.
Chromatographic analysis of procyanidins in digested
fractions
The digested freeze-dried fractions (chyme, pellet, IN and
OUT) were dissolved in acetone–Milli-Q water–acetic acid
(70:29·5:0·5, v/v/v) at a ratio of 1:5. The tubes were vortexed
for 5 min and centrifuged at 12 500 rpm. The supernatant con-
taining the solubilised phenols was filtered through 0·22mm
nylon filters before chromatographic analysis by ultraperfor-
mance liquid chromatography–MS/MS using a Waters
Acquity ultraperformance liquid chromatography system
(Waters, Milford, MA, USA), equipped with a binary pump
system (Waters)(32). The ultraperformance liquid chromato-
graphy analyses were performed using an Acquity high
strength silica T3 column (100 mm £ 2·1 mm inner diameter,
1·8mm particle size; Waters) with a binary mobile phase.
Solvent A was water–acetic acid (0·2 %), and the solvent as
acetonitrile. Catechin and epicatechin were quantified using
the curves of the respective standards. Epigallocatechin,
epicatechin gallate and epigallocatechin gallate were quanti-
fied using the epicatechin curve. The PC, dimers and trimers
were quantified with the calibration curves of the respective
standards. The oligomers from tetramer to heptamer were
quantified with the trimer calibration curve. The results of
the quantification of the PC in pellet (non-soluble fraction)
are expressed as mmol per g of pellet, and the results of the
quantification of the PC in the chyme (soluble fraction), IN
and OUT fractions are expressed in mM.
Pharmacokinetic study
Rat plasma samples were obtained from 3-month-old male
Wistar rats weighing between 370 and 420 g and were pur-
chased from Charles River Laboratories (Barcelona, Spain).
The Animal Ethics Committee of the Rovira i Virgili Univer-
sity approved all the procedures. The rats were housed in tem-
perature-controlled rooms (228C) and subjected to a standard
12 h light–12 h dark cycle (with a light period of 09.00–
21.00 hours). All the animals were fed a standard diet of
PanLab A04 (Panlab, Barcelona, Spain) and water.
After the animals had been in fasting conditions for
between 16.00 and 17.00 hours with only access to tap
water, two experiments were carried out: a dose of the PC-
rich extract, 1 g GSPE per kg of body weight dissolved in
water; a dose of 2 g carbohydrate-rich food þ 1 g GSPE for
kg of body weight dissolved in water, which was adminis-
tered to the rats by intragastric gavage. Three animals per
experiment were terminally anaesthetised with ketamine–
xylazine and euthanised by exsanguinations at 0 h (fasting
conditions), 1, 2 and 4 h (postprandial conditions). Blood
samples were collected from the abdominal aorta with
heparin-moistened syringes. The plasma samples were
obtained by centrifugation (2000 g, 30 min at 48C) and
stored at 2808C until the chromatographic analysis of the
PC. The identification of the PC metabolites was performed
by analyses in MS (full-scan mode) and MS/MS (based on
neutral loss scan and product ion scan mode)(33). First, ana-
lyses were carried out in the full-scan mode (from 419 to
1200 m/z) by applying different cone voltages from 20 to
60 V. When low cone voltages were applied, the MS spec-
trum gave information about the precursor ion or the
[M 2 H]2. In contrast, when high cone voltages were
applied, specific fragment ions were generated and the MS
spectrum gave information about their structure. The struc-
tural information was also verified by using product ion
scan and neutral loss scan in the MS/MS mode.
All the samples were analysed in triplicate by ultraperfor-
mance liquid chromatography–MS/MS according to the
method in Serra et al. (33). The quantification of the free
forms of the PC and their metabolites in the plasma samples
was done using the calibration curves of the respective
free forms, and the concentrations were expressed as catechin
or epicatechin equivalents.
Statistical analysis
All the data are expressed as the mean of three replicates.
In order to simplify the results shown in the tables, we omitted
the standard deviation because all these values were lower
than 10 %. The data were analysed by a one-way ANOVA
test to assess the effect of the carbohydrate-rich food on the
in vitro digestibility and in vivo pharmacokinetics of PC
from the GSPE extract. A significant difference is considered
at a level of P,0·05. All the statistical analysis was carried
out using STATGRAPHICS Plus 5.1.
Results
Evaluation of the stability of procyanidins in digestion by the
in vitro simulated digestion model
The first part of the study was focused on the evaluation of the
stability of PC during digestion using an in vitro model. The
composition of the GSPE used as a PC and proanthocyanidin
source in the study is summarised in Table 1. Dimers and
trimers were the most abundant compounds with 250·18 and
1568·72mmol/g extract, respectively. The digestion procedure
was applied to GSPE dissolved in water, and the same extract
was mixed with cereal-based food in order to evaluate the
influence of the food matrix with a high-carbohydrate content
on the digestion stability of the PC.
The compounds determined initially in GSPE (Table 1)
were analysed in all fractions of in vitro digestions to evaluate
their digestibility and stability. After the gastric step, the con-
tent of PC and proanthocyanidins was measured in the soluble
and non-soluble fractions, respectively, called the chyme and
pellet (Fig. 1), and the results were expressed as mmol of
concentration in the chyme fraction and as mmol per g of
A. Serra et al.946
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pellet (Table 2). After the gastric step, the amount of PC in the
chyme was higher than in the pellet fraction independently of
the presence of the carbohydrate-rich food in the digestion
mixture. The PC oligomers, dimers to heptamers, showed
higher concentrations than the monomers (catechin and epica-
techin) in the chime and pellet fractions, the trimer form being
the most abundant compound in the gastric fractions, reaching
a concentration of 50 279·77mmol in the chyme fraction after
the gastric step. Nevertheless, forms with a high degree of pol-
ymerisation (pentamer, hexamer and heptamer) were not
detected in pellet fraction.
After the duodenal step, an important loss of PC was
observed, and most were retained in the non-dialysable frac-
tion (IN). Nevertheless, dimers and trimers were quantified
in the dialysable (OUT) fraction (Fig. 1), as well as the mono-
meric structures. As a consequence of the duodenal digestion
conditions, decomposition of oligomeric forms was observed
in the respective monomeric forms. Additionally to the depo-
lymerisation of GSPE, a decrease in the ratio catechin/epicate-
chin was observed in the digestion mixture. Initially, in the
GSPE extract, this ratio was approximately 1·1 and after
digestion, a change in the ratio of roughly 0·7 was observed
in all fractions.
Finally, the comparative analysis between the concen-
trations of the different PC in the digestion mixtures revealed
that the presence of carbohydrate-rich food, as a source of
carbohydrates, showed a significant effect on the digestibility
of PC in the in vitro digestion model. When PC and proantho-
cyanidins were submitted to digestion together with carbo-
hydrate-rich food, the amount of catechin and epicatechin
present in the digestion mixture after the gastric step was sig-
nificantly higher (P,0·05) (Table 2). By contrast, the concen-
tration of the other compounds was greater when GSPE was
digested without carbohydrate-rich food. Greater differences
were observed in the non-soluble fraction (pellet) (Fig. 1),
showing a higher concentration of PC (P,0·05) when the
extract was digested with carbohydrate-rich food. By contrast,
the effect of carbohydrates on the digestibility during duode-
nal digestion was lower. Thus, the concentration of PC in
the dialysed fraction (OUT) was similar independently of
the presence of carbohydrates, with the exception of the epi-
gallocatechin gallate that showed a lower concentration
(P,0·05) in the presence of carbohydrates. On the other
hand, significant differences were observed in the non-dialysa-
ble fraction (IN), except the forms with a higher degree of pol-
ymerisation (pentamers to heptamers), which showed the same
concentration under the two digestion conditions. However, no
clear tendency was observed in the results of non-dialysable
(IN) fraction in relation to the presence or absence of
carbohydrates.
Pharmacokinetic of procyanidins
Figs. 2 and 3 show the results of the pharmacokinetic study of
rat plasma after the ingestion of GSPE without and with
carbohydrate-rich food. Under basal conditions (time ¼ 0),
PC were not detected in rat plasma. Two hours after the
GSPE ingestion, several metabolites, such as catechin glucur-
onide and epicatechin glucuronide, reached peak plasma con-
centrations with 6·24 and 9·74 nM, respectively, when GSPE
was ingested with carbohydrate-rich food, and 6·32 and
8·71 nM when GSPE is ingested without carbohydrate-rich
food. In contrast, the concentration of PC, free forms of
Table 2. Procyanidin and proanthocyanidin contents in the different fractions of the gastric and duodenal steps of the simulated gastrointestinal
digestion of grape seed procyanidin extract (GSPE) without and with carbohydrate-rich food
GSPE GSPE þ carbohydrate-rich food
Gastric Duodenal Gastric Duodenal
Compound Chyme (mM) Pellet (mmol/g) OUT (mM) IN (mM) Chyme (mM) Pellet (mmol/g) OUT (mM) IN (mM)
Catechin 1755a 7·4a 95a 451a 1928b 37b 83a 608b
Epicatechin 2221a 9·6a 126a 613a 2499b 42b 114a 823b
Epigallocatechin 258a 0·49a 2·6a 37a 186b 1·41b 2·4a 34·5b
Epicatechin gallate 6305a 29·8a 109a 1772a 5272b 191b 72b 2111b
Epigallocatechin gallate 136a 0·409a 0·80a 28·7a 91b 1·9b 0·65a 25·3b
Dimer 12 953a 37·1a 197a 3517a 11 485b 124b 168a 4005b
Trimer 50 279a 109a 147a 8101a 37 505b 356b 111a 8659a
Tetramer 10 076a 21·0a 0·25a 1748a 5368b 82b ND 1673b
Pentamer 16·8a ND ND 12·7a ND ND ND ND
Hexamer 185a ND ND 16·9a 49b ND ND 6·6a
Heptamer 0·66a ND ND 0·73a 2·34b ND ND ND
OUT, fraction found outside dialysis solution; IN, fraction found inside dialysis solution; ND, not detected.
a,b Mean values within a column with unlike superscript letters were significantly different (P,0·05) between GSPE þ carbohydrate-rich food and GSPE in each digestion step
(unpaired Student’s t test).
Table 1. Phenolic composition of grape seed procyanidin extract
(GSPE)*
Compound Concentration (mmol/g)
Catechin 58
Epicatechin 52
Epigallocatechin 5·50
Epicatechin gallate 89
Epigallocatechin gallate 1·40
Dimer 250
Trimer 1568
Tetramer 8·8
Pentamer 0·73
Hexamer 0·38
Heptamer 0
* The results are expressed as mmol/g of GSPE.
Bioavailability of procyanidin 947
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Fig. 2. Pharmacokinetic curves of monomeric forms, (–B–) catechin, (–K–) epicatechin (–O–) and epicatechin gallate (a and b), and polymeric forms, (–X–)
dimer and (–W–) trimer (c and d), detected in rat plasma collected between 0 and 4 h after the ingestion of grape seed procyanidin extract with and without carbo-
hydrate-rich food. The results are expressed as nM. * Mean value was significantly different from that without carbohydrate-rich food (P,0·05; unpaired Student’s t
test).
Fig. 3. Pharmacokinetic curves of grape seed procyanidin extract (GSPE) metabolites according to the monomer structure, being (–S–) catechin methyl glucuro-
nide, (– þ –) catechin glucuronide and ( ) catechin methyl sulphate (a and b), and (–A–) epicatechin methyl glucuronide, (–V–) epicatechin glucuronide and
( ) epicatechin methyl sulphate (c and d), detected in rat plasma collected between 0 and 4 h after the ingestion of GSPE with and without carbohydrate-rich
food. The results are expressed as nM. * Mean value was significantly different from that without carbohydrate-rich food (P,0·05; unpaired Student’s t test).
A. Serra et al.948
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dimers and trimers in the plasma reached a maximum 1 h after
administration. These free forms appeared in the plasma faster
than the glucuronidated forms of the monomers. Dimer con-
centration was greater after the ingestion of GSPE without
the presence of carbohydrate-rich food, reaching a postpran-
dial concentration in plasma of 0·57 nM as against 0·12 nM
when the GSPE was ingested with carbohydrate-rich food.
Similarly, the presence of the carbohydrate-rich food reduced
the maximum concentration of the trimer in the plasma. Non-
conjugated forms of monomers (catechin, epicatechin and
epicatechin gallate) were present in the plasma at very low
concentration, less than 0·03 nM under the two experimental
conditions. Glucuronidated forms of catechin and epicatechin
were the most abundant, and the second most abundant metab-
olite was methyl-glucuronidated forms, independently of the
presence of the carbohydrate-rich meal.
Comparison between in vitro digestion method and in vivo
bioavailability
Fig. 4(a) and (b) show the percentage of different PC present
in the dialysed fraction (OUT) of the duodenal digestion mix-
ture corresponding to the in vitro digestion model (Fig. 1); and
Fig. 4(c) and (d) show the percentage of free PC and their
metabolites in the rat plasma after the ingestion of the GSPE
extract (in vivo model). The expression of the quantification of
PC as percentages in both the in vitro and in vivo models aims
to normalise the results to facilitate their comparative analysis
independently of whether the concentrations of the compounds
varied widely in both models. In all the plasma samples, epi-
catechin was the most abundant compound, glucuronidated
forms being 88 and 89 % of the total, when GSPE was
digested alone and with carbohydrate-rich food, respectively.
This was followed by catechin, which was the second most
abundant compound. Nevertheless, the dimer structure was
the most substantial PC quantified in the dialysed fraction
(OUT) after the duodenal step of the in vitro digestion
model, reaching a percentage of almost 30 % (Fig. 4(a) and
(b)); however, this compound was a very low percentage in
the plasma samples (1·69 % when the GSPE was administered
alone and 0·35 % when it was administered with carbohydrate-
rich food) (Fig. 4(c) and (d)). The quantification of the trimer
in the plasma samples showed percentages under 1 %, inde-
pendently of the presence or absence of carbohydrate-rich
food in the intake, whereas its percentage in the dialysed frac-
tion (OUT) of the duodenal digestion was higher, close to
20 %. Epicatechin gallate behaved similarly.
Discussion
We have shown, using in vitro cell lines, that dimer and trimer
PC are the most powerful molecules that mimic the in vivo
Fig. 4. (a and b) In vitro and in vivo grape seed procyanidin extract (GSPE). Percentage of the catechin, epicatechin, epicatechin gallate, dimer and trimer in the
dialysed fraction (fraction found inside dialysis solution) of the duodenal mixture. (c and d) In vitro and in vivo GSPE þ carbohydrate-rich food. Percentage of the
catechin, epicatechin and their respective metabolites, epicatechin gallate, dimer and trimer in the postprandial rat plasma.
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effects of GSPE(2). As there is some controversy about the
bioavailability of dimeric and trimeric PC, we used a combi-
nation of in vitro and in vivo models in order to measure the
bioavailability of dimer and trimer PC. The effects of the
digestion process on their stability and the food matrix
effect on their potential bioaccessibility were also evaluated.
The GSPE used as a source of PC in the present study con-
tained a substantial amount of high molecular weight poly-
meric PC, dimer and trimer being the most abundant. After
the simulated in vitro digestion, these PC oligomers were pre-
sent in high concentration in all digestion fractions, showing
an important stability under gastric and duodenal digestion
conditions. The most important aspect is related to the
increase in their concentration observed in the digestion mix-
tures after the two steps. This is probably related to the partial
hydrolysis of the highly polymerised molecules or condensed
tannins in the GSPE. However, the pharmacokinetic study
revealed a limited absorption. The limitation in the diffusion
across the epithelial cells could explain the nanomolar levels
quantified in the postprandial rat plasma after the intake, at
micromolar levels, of the oligomeric PC. The pharmacokinetic
results shown in the present study agree with previous
research that has shown the presence of some dimers (B2
and B5), detected at nanomolar levels, in the plasma of rats
given cocoa extracts(35,36). By contrast, in other studies, the
dimer (B3) and trimer (C2) were not detected in the plasma
of rats given purified compounds(37). With regard to the
metabolism, the major metabolites observed in rat plasma in
the present study were glucuronidated forms of catechin and
epicatechin, although there were also high levels of methyl-
ated-glucuronide forms. Similarly, a previous study by
Spencer et al. (38) reported that methylated-glucuronide
forms were the most bioavailable forms in the small intestine.
When the GSPE extract was submitted to the in vitro diges-
tion model, there were high concentrations of the monomers
catechin and epicatechin and mainly the dimer and trimer oli-
gomeric flavanols in the gastric fractions (chyme and pellet),
showing an important stability under acid conditions. Similar
results were observed by Spencer et al. (9). The results of pan-
creatic digestion showed a lesser decrease in the concentration
of PC with a high degree of polymerisation, because a slight
decomposition of the oligomeric forms into monomers was
seen after the duodenal digestion, being greater when the
extract was digested with carbohydrate-rich food. Thus, PC
were less stable under alkaline conditions (pH ¼ 6·9) and in
the presence of digestive enzymes than under acid conditions
in the gastric step. After the evaluation of the stability of the
PC under digestion conditions, the next phase was focused on
the in vitro estimation of the potential bioaccessibility and
potential absorption in the systemic circulation in biological
systems. For this proposal, a dialysis phase was considered
for the duodenal step, estimating the passive diffusion of
the digested PC solubilised in the water phase (IN) (Fig. 1).
Comparing the total concentration of PC in the duodenal
mixture (IN and OUT) after the duodenal digestion with the
total concentration in the digestion mixture after the gastric
step, a substantial loss was observed. The losses in the PC
content of the duodenal digestion mixture could be attributed
to the large oligomers being held on the dialysis membrane,
reducing the recovery of the PC to be analysed during the
washing of the dialysis tub. Additionally, the large oligomers
could reduce the membrane’s surface. This problem was also
reported by Bermu´dez-Soto et al. (39), who argued that the
dialysis membrane as a means of estimating availability for
absorption had some limitations. However, some authors
have reported that PC are unstable under alkaline con-
ditions(36,40,41), and this instability also may explain the
decrease of PC concentrations in the digestion mixture after
pancreatic digestion. According to Rios et al. (19), the stability
of PC in the stomach and their very limited absorption in the
small intestine suggest that they may influence digestion or the
physiology of the gut through direct interactions with the gut
mucosa and gut lumen solutes.
On the other hand, a decrease in the catechin:epicatechin
ratio was observed during digestion in the in vitro model in
the present study. The increase in epicatechin could be the
consequence of the depolymerisation of GSPE, which is
mainly composed of epicatechin units, into monomeric
forms. However, in the study by Rios et al. (19), no epimerisa-
tion was observed during the stomach digestion and oligomers
to pentamers were stable during stomach transit. The results of
the present study corresponding to the in vivo model revealed
epicatechin and its metabolites as the predominant plasma
monomer absorbed (Fig. 2). This fact has been also observed
by other authors(42) who showed in human subjects that after
consuming a cocoa beverage containing equal amounts of epi-
catechin and catechin, the former was identified as the predo-
minant plasma flavanol absorbed.
The pharmacokinetic study of the rat plasma revealed that
the glucuronidated forms were the most abundant metabolite.
These results agree with those in Vaidyanathan & Walle (43)
who observed that rat liver microsomes efficiently glucuroni-
date epicatechin. Glucuronidation of catechin has been
described to be more active in rat livers than in the intestine,
in both in vitro (44) and in vivo models(45). Traces of glucuro-
nidated and sulphated metabolites from monomers have also
been detected in the lumen of gut from rats treated with
GSPE(1). One of the most important factors determining the
metabolic fate of polyphenols in human subjects is the quan-
tity ingested(46). According to Hacket et al. (47), when food
polyphenols are administered at a pharmacological dose,
they are found in free forms in the blood. By contrast, when
the dose is decreased to only a few milligrams, the monomers
were conjugated and no free forms were detected(18). Related
to this, in the present study, the free forms of catechin and epi-
catechin were found at very low concentrations in the plasma
samples after the ingestion of GSPE. The present results
may be coherent with the dose administered to the rats,
because the dose used is an intermediate position between
the pharmacological dose and typical dose of polyphenols
present in rich foods.
The last objective in the present study was to evaluate the
effect of carbohydrate-rich foods on the bioavailability of
the GSPE. Relatively, little is known about the effect of
food on the bioavailability of PC. Food within the gastrointes-
tinal tract is known to markedly alter the oral absorption of
many xenobiotic compounds(48). In the present in vitro
study, when the extract was ingested with carbohydrate-rich
food, an enhanced uptake of the monomeric PC was observed.
This result is in agreement with the results in Schramm
et al. (26), who reviewed that the effect observed with carbo-
hydrate-rich foods (bread, sucrose and grapefruit juice) may
A. Serra et al.950
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have been mediated by a carbohydrate-specific effect on
gastrointestinal physiology (e.g. motility and/or secretion) or
a carbohydrate-specific enhancement of the activity of a yet
unidentified carbohydrate–flavanol transporter.
In conclusion, dimer and trimer PC are absorbable in vivo,
reaching maximum concentrations in the plasma as soon as 1 h
after PC ingestion. Their low concentrations in the plasma are
not the consequence of instability during the digestion process
as the in vitro digestion model shows high levels of dimer and
trimer after duodenal digestion. Moreover, absorption of dimer
and trimer PC is repressed by the simultaneous presence of
carbohydrate-rich food.
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